Phacoemulsification with goniosynechialysis versus trabeculectomy for primary angle-closure glaucoma
Official title: Comparison of Phaco Surgery and Goniosynechialysis Versus Trabeculectomy Outcomes in Glaucoma Patients
Run by University of Medicine and Pharmacy at Ho Chi Minh City · NCT06952153 · Data updated 2026-11-12
This trial will see if phacoemulsification plus goniosynechialysis controls eye pressure and causes fewer complications than trabeculectomy in adults with primary angle-closure glaucoma.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 82 (estimated) |
| Sponsor | University of Medicine and Pharmacy at Ho Chi Minh City Academic / other |
| Locations | 1 site (Ho Chi Minh City) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | July 30, 2027 |
| Study ends | September 10, 2027 |
| Registry record updated | September 11, 2025 |
| Trial ID | NCT06952153 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 40 or older with primary angle-closure glaucoma, ≥180° peripheral anterior synechiae, cataract grade 1–3, IOP >21 mmHg despite medication, and BCVA ≥ 0.3 logMAR.
✕Probably not a fit
Patients with only light perception vision, secondary angle-closure etiologies, prior ocular surgery or laser PI, very advanced corneal disease, chronic steroid use, very dense cataract (LOCS III grade 4–5), or poor follow-up are unlikely to benefit from randomization in this comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, parallel-group, single-masked trial will assign adults with primary angle-closure glaucoma to either phacoemulsification with goniosynechialysis (Phaco-GSL) or trabeculectomy with 5‑fluorouracil. Allocation is stratified by age and disease severity, and all procedures are performed by experienced glaucoma surgeons following standardized surgical and postoperative protocols. Key outcomes include intraocular pressure at predefined intervals, IOP reduction from baseline, rates of postoperative complications, visual acuity recovery, and need for glaucoma medications. Participants attend scheduled visits (e.g., 1 week, 1 month, 3 months, 6 months, 12 months) for standardized eye exams and pressure checks to compare groups.
Why it matters
Potential benefit: If successful, Phaco-GSL could provide similar IOP control with fewer complications and faster visual recovery than trabeculectomy.
How similar studies have gone: Previous nonrandomized studies and smaller series have suggested Phaco-GSL can lower IOP and reduce medication need in PACG, but high-quality randomized comparisons directly versus trabeculectomy are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 40 years * Peripheral anterior synechiae (PAS) \>180° * Glaucomatous optic neuropathy with visual field loss * Intraocular pressure (IOP) \> 21 mmHg despite medication * Ability to consent and comply with follow-up * Cataract grade 1 to 3 according to LOCS III * Best corrected visual acuity (BCVA) ≥ 0.3 logMAR (equivalent to 20/40 Snellen or worse) Exclusion Criteria: * Very advanced glaucoma (only light perception vision) * Secondary angle-closure etiologies * Prior ocular surgeries or laser peripheral iridotomy (PI) * Allergy to 5-fluorouracil (5-FU), if used postoperatively * Irreversible corneal disease * Chronic corticosteroid use * Poor follow-up compliance * Cataract grade 4 or 5 (LOCS III) * Phacomorphic, phacolytic, or subluxated cataracts
Where it's running
-
HCMC University of Medicine and Pharmacy
Ho Chi Minh City, Vietnam Recruiting
Study contacts
- Study coordinator: Hai Thanh Le, MSc
- Email: haileopto@gmail.com
- Phone: +61 450390405
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
Multi-omics analysis linking zonular laxity and primary angle‑closure glaucoma
It will test whether molecular differences in eye fluid, blood, and the anterior lens capsule link zonular laxity to primary angle‑closure glaucoma in adults aged 50 and older.
-
Vitreous zonule and its role in primary angle-closure glaucoma.
This project will try 3D ultrasound imaging to see if the vitreous zonule contributes to angle-closure glaucoma in adults with or at risk for primary angle-closure disease and in healthy people.
-
Kahook Dual Blade goniotomy added to cataract surgery for chronic angle-closure glaucoma
This trial will test whether adding Kahook Dual Blade goniotomy to cataract surgery and goniosynechialysis better lowers eye pressure in people aged 40 and older with chronic primary angle-closure glaucoma and cataract.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.